Because EPR is not prescriptive about implementation, it provides incentives for businesses to voluntarily reduce packaging and get innovative with materials and design.
Eric Park, of Ziba, a design consultancy, reckons companies must also think about drug delivery systems and patient-friendly packaging, which could create a new kind of branded intellectual property that might be more defensible than drug patents.